Starbucks Q1 2026 Earnings Analysis
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Starbucks Q1 2026 Earnings Analysis
-
ナレーター：
-
著者：
概要
JORDAN: Absolutely, Alex. But before we get into the details, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.
ALEX: Thanks for that, Jordan. Now, let's talk about what CEO Brian Niccol is calling the "Back to Starbucks" plan. The headline here is that they're finally seeing transaction-led growth again. Revenue hit $9.9 billion, up 5%, with global comparable store sales growing 4%.
JORDAN: What really caught my attention was the U.S. performance. They had 4% comp growth with 3% transaction growth - and this is the first time in eight quarters that their Starbucks Rewards transactions grew year-over-year. That's huge because it means people are actually coming back to the stores more frequently.
ALEX: Right, and it wasn't just rewards members. Non-rewards customers grew transactions even faster than rewards members. Niccol made a point about this - he said when he first arrived, non-rewards customers had been declining consistently, which is never healthy for a business.
JORDAN: The interesting thing is how they're driving this growth. It's not through discounting - they specifically mentioned that value perception scores held strong paired with average ticket growth. They're creating value through what they call the "Green Apron service model" and menu innovation, not price cuts.
ALEX: Let's talk about that Green Apron model because it seems to be the foundation of everything. Essentially, they've invested heavily in labor - bigger rosters, better training, new customer service standards. CFO Catherine Smith mentioned they're anniversarying these investments by Q4, which should help margins going forward.
JORDAN: The proof is in the pudding too. Those 650 pilot stores that got the full Green Apron treatment are still outperforming the rest of the fleet by about 200 basis points in comp growth. And get this - they're hitting their four-minute service targets even with meaningful transaction growth. That's operational excellence.
ALEX: Now, the earnings picture is more complicated. EPS came in at $0.56, down 19% year-over-year. Operating margins contracted 180 basis points to 10.1%. But management is basically saying "top line first, then earnings will follow."
JORDAN: Exactly. And they're not just hoping margins improve - they have a concrete plan. Niccol announced a $2 billion cost efficiency program over the next two years covering procurement, technology, and general administrative functions. Plus, they expect coffee prices and tariff pressures to peak in Q2 and find relief in the back half of the year.
ALEX: The guidance for fiscal 2026 reflects this cautious optimism. They're projecting 3% or better global comp sales growth, but EPS guidance of $2.15 to $2.40 is pretty wide. When an analyst asked about scenarios for the high and low end, Niccol basically said it comes down to maintaining comp performance.
JORDAN: Speaking of guidance, there's a big strategic shift happening in China. They're forming a joint venture with Boyu Capital where Boyu gets up to 60% of retail operations and Starbucks keeps 40% plus the brand and IP licensing. This could be about 40 basis points accretive to consolidated margins annually.
ALEX: That China move is fascinating because it shows they're willing to give up control for better local execution. China had 7% comp growth in Q1 - their third consecutive quarter of growth. Sometimes the best strategy is partnering with someone who knows the market better.
JORDAN: One thing I loved from the Q&A was when they talked about the afternoon opp
This episode includes AI-generated content.
まだレビューはありません